Annual Report 2025

Annual Report 2025

Introduction

The year 2025 marked a significant milestone for “Avalon Pharma” as a strategic partner in realizing the aspirations of Saudi Arabia’s Vision 2030. During this year, we succeeded in elevating national healthcare standards, achieving sustainable growth, and pursuing qualitative expansion that strengthened the company’s position both locally and regionally. Through an institutional approach that places innovation and quality at the forefront of our operations, we were able to consolidate our leadership role and develop advanced medical solutions to enhance the healthcare ecosystem and deliver sustainable value to all stakeholders.

Building on this performance, we are pleased to present this report, which documents the key milestones, financial results, and operational achievements of the year. It reflects the Board of Directors’ visionary guidance in setting growth-supportive policies and empowering the executive management to achieve excellence, alongside the collective efforts of all company personnel. The information presented in this report demonstrates our ability to turn challenges into opportunities and continue investing in advanced pharmaceutical technologies, ensuring sustained institutional excellence and keeping pace with the rapid transformations in the healthcare sector.